Rilzabrutinib, (Z)- is a chemical compound that functions as a Bruton tyrosine kinase inhibitor. It is a pharmaceutical raw material used in the manufacturing of research compounds for kinase-related studies.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1575596-29-0
Tolebrutinib
Bruton tyrosine kinase inhibitor
PCI-32765 (Racemate)
Bruton tyrosine kinase inhibitor
Diroximel fumarate
active pharmaceutical ingredient for multiple sclerosis
IFN-gamma Antagonist
IFN-gamma antagonist peptide
2-(2-Amino-1,3-thiazol-4-yl)-N-(4-(2-((2-phenylethyl)amino)ethyl)phenyl)acetamide
pharmaceutical impurity reference standard
CROMOLYN SODIUM
active pharmaceutical ingredient
(Z)-2-[(3R)-3-[4-amino-3-(2-fluoro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile
LCFFREMLXLZNHE-IURUZKCNSA-N
CC(C)(/C=C(/C#N)\C(=O)N1CCC[C@H](C1)N2C3=NC=NC(=C3C(=N2)C4=C(C=C(C=C4)OC5=CC=CC=C5)F)N)N6CCN(CC6)C7COC7